[1]
The current status of angiography in the evaluation of cancer patients., Reuter SR,, Cancer, 1976 Jan [PubMed PMID: 942883]
[2]
Therapy for hepatocellular cancer with intrahepatic arterial adriamycin and 5-fluorouracil combined with whole-liver irradiation: a Northern California Oncology Group Study., Friedman MA,Volberding PA,Cassidy MJ,Resser KJ,Wasserman TH,Phillips TL,, Cancer treatment reports, 1979 Nov-Dec [PubMed PMID: 230895]
[3]
Characterization of the middle hepatic artery and its relevance to living donor liver transplantation., Wang S,He X,Li Z,Peng Z,Tam NL,Sun C,Hu A,Huang J,, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2010 Jun [PubMed PMID: 20517907]
[4]
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis., Mazzaferro V,Regalia E,Doci R,Andreola S,Pulvirenti A,Bozzetti F,Montalto F,Ammatuna M,Morabito A,Gennari L,, The New England journal of medicine, 1996 Mar 14 [PubMed PMID: 8594428]
[5]
Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients., Okuda K,Ohtsuki T,Obata H,Tomimatsu M,Okazaki N,Hasegawa H,Nakajima Y,Ohnishi K,, Cancer, 1985 Aug 15 [PubMed PMID: 2990661]
[6]
A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators.,, Hepatology (Baltimore, Md.), 1998 Sep [PubMed PMID: 9731568]
[7]
Prognosis of hepatocellular carcinoma: the BCLC staging classification., Llovet JM,Brú C,Bruix J,, Seminars in liver disease, 1999 [PubMed PMID: 10518312]
[8]
Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients., Leung TW,Tang AM,Zee B,Lau WY,Lai PB,Leung KL,Lau JT,Yu SC,Johnson PJ,, Cancer, 2002 Mar 15 [PubMed PMID: 11920539]
[9]
Kudo M,Chung H,Osaki Y, Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). Journal of gastroenterology. 2003 [PubMed PMID: 12673442]
[10]
Kee KM,Wang JH,Lin CY,Wang CC,Cheng YF,Lu SN, Validation of the 7th edition TNM staging system for hepatocellular carcinoma: an analysis of 8,828 patients in a single medical center. Digestive diseases and sciences. 2013 Sep [PubMed PMID: 23703450]
[11]
Staging systems for hepatocellular carcinoma: Current status and future perspectives., Kinoshita A,Onoda H,Fushiya N,Koike K,Nishino H,Tajiri H,, World journal of hepatology, 2015 Mar 27 [PubMed PMID: 25848467]
[13]
Lencioni R,de Baere T,Soulen MC,Rilling WS,Geschwind JF, Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data. Hepatology (Baltimore, Md.). 2016 Jul [PubMed PMID: 26765068]
[14]
Practice guidelines for adult antibiotic prophylaxis during vascular and interventional radiology procedures. Written by the Standards of Practice Committee for the Society of Interventional Radiology and Endorsed by the Cardiovascular Interventional Radiological Society of Europe and Canadian Interventional Radiology Association [corrected]., Venkatesan AM,Kundu S,Sacks D,Wallace MJ,Wojak JC,Rose SC,Clark TW,d'Othee BJ,Itkin M,Jones RS,Miller DL,Owens CA,Rajan DK,Stokes LS,Swan TL,Towbin RB,Cardella JF,, Journal of vascular and interventional radiology : JVIR, 2010 Nov [PubMed PMID: 21029949]
[15]
Risk factors for liver abscess formation after hepatic chemoembolization., Kim W,Clark TW,Baum RA,Soulen MC,, Journal of vascular and interventional radiology : JVIR, 2001 Aug [PubMed PMID: 11487677]
[16]
Chemoembolization of hepatic neoplasms: safety, complications, and when to worry., Gates J,Hartnell GG,Stuart KE,Clouse ME,, Radiographics : a review publication of the Radiological Society of North America, Inc, 1999 Mar-Apr [PubMed PMID: 10194787]
[17]
Particle embolization for hepatocellular carcinoma., Brown KT,Nevins AB,Getrajdman GI,Brody LA,Kurtz RC,Fong Y,Blumgart LH,, Journal of vascular and interventional radiology : JVIR, 1998 Sep-Oct [PubMed PMID: 9756073]
[18]
Moxifloxacin prophylaxis for chemoembolization or embolization in patients with previous biliary interventions: a pilot study., Khan W,Sullivan KL,McCann JW,Gonsalves CF,Sato T,Eschelman DJ,Brown DB,, AJR. American journal of roentgenology, 2011 Aug [PubMed PMID: 21785063]
[19]
Effectiveness of an aggressive antibiotic regimen for chemoembolization in patients with previous biliary intervention., Patel S,Tuite CM,Mondschein JI,Soulen MC,, Journal of vascular and interventional radiology : JVIR, 2006 Dec [PubMed PMID: 17185688]
[20]
Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolization treatment of liver tumors., Geschwind JF,Kaushik S,Ramsey DE,Choti MA,Fishman EK,Kobeiter H,, Journal of vascular and interventional radiology : JVIR, 2002 Nov [PubMed PMID: 12427817]
[21]
Addendum of newer anticoagulants to the SIR consensus guideline., Patel IJ,Davidson JC,Nikolic B,Salazar GM,Schwartzberg MS,Walker TG,Saad WE,, Journal of vascular and interventional radiology : JVIR, 2013 May [PubMed PMID: 23622037]
[22]
Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy., Brown DB,Nikolic B,Covey AM,Nutting CW,Saad WE,Salem R,Sofocleous CT,Sze DY,, Journal of vascular and interventional radiology : JVIR, 2012 Mar [PubMed PMID: 22284821]
[23]
Drug-eluting bead therapy in primary and metastatic disease of the liver., Carter S,Martin Ii RC,, HPB : the official journal of the International Hepato Pancreato Biliary Association, 2009 Nov [PubMed PMID: 20495705]
[24]
Complications associated with transcatheter arterial embolization for hepatic tumors., Sakamoto I,Aso N,Nagaoki K,Matsuoka Y,Uetani M,Ashizawa K,Iwanaga S,Mori M,Morikawa M,Fukuda T,Hayashi K,Matsunaga N,, Radiographics : a review publication of the Radiological Society of North America, Inc, 1998 May-Jun [PubMed PMID: 9599386]
[25]
Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization., Chung JW,Park JH,Han JK,Choi BI,Han MC,Lee HS,Kim CY,, Radiology, 1996 Jan [PubMed PMID: 8539401]
[26]
A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation., Yao FY,Hirose R,LaBerge JM,Davern TJ 3rd,Bass NM,Kerlan RK Jr,Merriman R,Feng S,Freise CE,Ascher NL,Roberts JP,, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2005 Dec [PubMed PMID: 16315294]
[27]
Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma., Otto G,Herber S,Heise M,Lohse AW,Mönch C,Bittinger F,Hoppe-Lotichius M,Schuchmann M,Victor A,Pitton M,, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2006 Aug [PubMed PMID: 16826556]
[28]
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival., Llovet JM,Bruix J,, Hepatology (Baltimore, Md.), 2003 Feb [PubMed PMID: 12540794]
[29]
Lo CM,Ngan H,Tso WK,Liu CL,Lam CM,Poon RT,Fan ST,Wong J, Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology (Baltimore, Md.). 2002 May [PubMed PMID: 11981766]
[30]
Barone M,Ettorre GC,Ladisa R,Schiavariello M,Santoro C,Francioso G,Vinciguerra V,Francavilla A, Transcatheter arterial chemoembolization (TACE) in treatment of hepatocellular carcinoma. Hepato-gastroenterology. 2003 Jan-Feb [PubMed PMID: 12630019]
[31]
Kudo M,Han G,Finn RS,Poon RT,Blanc JF,Yan L,Yang J,Lu L,Tak WY,Yu X,Lee JH,Lin SM,Wu C,Tanwandee T,Shao G,Walters IB,Dela Cruz C,Poulart V,Wang JH, Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial. Hepatology (Baltimore, Md.). 2014 Nov [PubMed PMID: 24996197]
[32]
Burrel M,Reig M,Forner A,Barrufet M,de Lope CR,Tremosini S,Ayuso C,Llovet JM,Real MI,Bruix J, Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design. Journal of hepatology. 2012 Jun [PubMed PMID: 22314428]
[33]
Meyer T,Fox R,Ma YT,Ross PJ,James MW,Sturgess R,Stubbs C,Stocken DD,Wall L,Watkinson A,Hacking N,Evans TRJ,Collins P,Hubner RA,Cunningham D,Primrose JN,Johnson PJ,Palmer DH, Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial. The lancet. Gastroenterology & hepatology. 2017 Aug [PubMed PMID: 28648803]
[34]
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma., Salem R,Gordon AC,Mouli S,Hickey R,Kallini J,Gabr A,Mulcahy MF,Baker T,Abecassis M,Miller FH,Yaghmai V,Sato K,Desai K,Thornburg B,Benson AB,Rademaker A,Ganger D,Kulik L,Lewandowski RJ,, Gastroenterology, 2016 Dec [PubMed PMID: 27575820]
[35]
Vilgrain V,Pereira H,Assenat E,Guiu B,Ilonca AD,Pageaux GP,Sibert A,Bouattour M,Lebtahi R,Allaham W,Barraud H,Laurent V,Mathias E,Bronowicki JP,Tasu JP,Perdrisot R,Silvain C,Gerolami R,Mundler O,Seitz JF,Vidal V,Aubé C,Oberti F,Couturier O,Brenot-Rossi I,Raoul JL,Sarran A,Costentin C,Itti E,Luciani A,Adam R,Lewin M,Samuel D,Ronot M,Dinut A,Castera L,Chatellier G, Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial. The Lancet. Oncology. 2017 Dec [PubMed PMID: 29107679]
[36]
Chow PKH,Gandhi M,Tan SB,Khin MW,Khasbazar A,Ong J,Choo SP,Cheow PC,Chotipanich C,Lim K,Lesmana LA,Manuaba TW,Yoong BK,Raj A,Law CS,Cua IHY,Lobo RR,Teh CSC,Kim YH,Jong YW,Han HS,Bae SH,Yoon HK,Lee RC,Hung CF,Peng CY,Liang PC,Bartlett A,Kok KYY,Thng CH,Low AS,Goh ASW,Tay KH,Lo RHG,Goh BKP,Ng DCE,Lekurwale G,Liew WM,Gebski V,Mak KSW,Soo KC, SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2018 Jul 1 [PubMed PMID: 29498924]